DEFINITIVE CONTRACT

INIMMUNE CORP - DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES

PIID: 75N93023C00042

Effective Date: Sep 30, 2023End Date: Closes in 814 days

Award $

$7.8M

Vendor

INIMMUNE CORP

Key Details

Dollars Obligated

$7.8M

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

Place of Performance

Description

DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES

Context & Analysis

Department of Health and Human Services obligated $7,776,786 to INIMMUNE CORP for development of sas a synthetic as01-like adjuvant system for influenza vaccines. Performance is located in MT. The contract is scheduled through Sep 29, 2028. This award is one of several similar procurements from Department of Health and Human Services — related awards are listed below.